US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alumis Inc.

24.80

-1.5200-5.78%

Post-market: 25.280.4800+1.94%18:14 EDT

Volume:1.55M

Turnover:38.82M

Market Cap:3.15B

PE:-8.67

High:26.26

Open:26.01

Low:24.25

Close:26.32

52wk High:30.60

52wk Low:2.76

Shares:127.20M

Float Shares:76.48M

Volume Ratio:0.77

T/O Rate:2.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8616

EPS(LYR):-2.8616

ROE:-86.68%

ROA:-73.36%

PB:10.47

PE(LYR):-8.67

Loading ...

Overview Company News Filings

U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle

Alumis initiated with a Strong Buy at Raymond James

Alumis CEO Martin Babler to Join Fireside Chat at Leerink Partners Global Healthcare Conference

Alumis Inc : Stifel Initiates Coverage With Buy Rating; Price Target $44

THOMSON REUTERS

Stifel Initiates Alumis at Buy With $44 Price Target

MT Newswires Live

U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP

Alumis to Participate in Upcoming February Investor Conferences

Alumis Initiated at Buy by Chardan Capital

Chardan Initiates Alumis at Buy With $37 Price Target

MT Newswires Live

Alumis Inc. (ALMS) Receives a Buy from Chardan Capital

13D Filings -- Barrons.com

Alumis (ALMS) Is Up 35.8% After Psoriasis Data And $300M Raise Has The Bull Case Changed?

Simply Wall St.

Alumis rises 10.2%

Insider Makes Bold Multimillion-Dollar Bet on Alumis Inc.

Form 4 | Alumis Inc. Director Akkaraju Srinivas acquired 588,235 shares.

ALUMIS INC. Director Foresite Capital Management VI LLC purchased 411,764 Shares.

ALUMIS Inc. Director James B. Tananbaum purchased 411,764 Shares.

Foresite Labs Reports Acquisition of Alumis Inc. Common Shares

Director and 10% Owner James B. Tananbaum Acquires Common Shares of Alumis Inc

Alumis Inc. Showcases Breakthrough TYK2 Inhibitor Results for Psoriasis and Lupus

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALMS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ALMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":24.8,"timestamp":1774641600000,"preClose":26.32,"halted":0,"volume":1549606,"hourTrading":{"tag":"盘后","latestPrice":25.28,"preClose":24.8,"latestTime":"18:14 EDT","volume":42753,"amount":1060330.705701,"timestamp":1774649692370,"change":0.48,"changeRate":0.019355,"amplitude":0.031452},"delay":0,"changeRate":-0.05775075987841943,"floatShares":76484700,"shares":127199333,"eps":-2.861649,"marketStatus":"Post-Mkt","change":-1.52,"latestTime":"03-27 18:22:55 EDT","open":26.01,"high":26.255,"low":24.25,"amount":38819319.37054,"amplitude":0.076178,"askPrice":25.5,"askSize":100,"bidPrice":24.24,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.861649,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774656000000},"marketStatusCode":4,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":26.32,"preHourTrading":{"tag":"盘前","latestPrice":26.01,"preClose":26.32,"latestTime":"09:29 EDT","volume":61957,"amount":1630448.0206,"timestamp":1774618199999,"change":-0.31,"changeRate":-0.011778,"amplitude":0.033815},"postHourTrading":{"tag":"盘后","latestPrice":25.28,"preClose":24.8,"latestTime":"18:14 EDT","volume":42753,"amount":1060330.705701,"timestamp":1774649692370,"change":0.48,"changeRate":0.019355,"amplitude":0.031452},"volumeRatio":0.769098,"impliedVol":1.3221,"impliedVolPercentile":0.5309},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","floatShares":76484700,"roa":"-73.36%","roe":"-86.68%","lyrEps":-2.861649,"volumeRatio":0.769098,"shares":127199333,"dividePrice":0,"high":26.255,"amplitude":0.076178,"preClose":26.32,"low":24.25,"week52Low":2.7601,"pbRate":"10.47","psRate":"131.17","week52High":30.6,"institutionHeld":0,"latestPrice":24.8,"eps":-2.861649,"divideRate":0,"volume":1549606,"delay":0,"ttmEps":-2.861649,"open":26.01,"prevYearClose":9.76,"prevWeekClose":25.06,"prevMonthClose":29.69,"prevQuarterClose":9.76,"fiveDayClose":25.06,"twentyDayClose":29.69,"sixtyDayClose":9.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"ALMS","fiscalQuarterEnding":"2025/12","expectedEps":-0.97,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":-0.95},{"market":"US","date":"2025-11-13","symbol":"ALMS","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-1.06},{"market":"US","date":"2025-08-13","symbol":"ALMS","fiscalQuarterEnding":"2025/06","expectedEps":-1.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.17},{"market":"US","date":"2025-05-14","symbol":"ALMS","fiscalQuarterEnding":"2025/03","expectedEps":-1.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2025-03-19","symbol":"ALMS","fiscalQuarterEnding":"2024/12","expectedEps":-1.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.4545,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5455,"analysts":11,"updateTime":1774065600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMS","date":"2026-03-26","current":-8.666332,"percent":0.086758,"low":-15.244382,"twenty":-3.951876,"median":-2.122286,"eighty":-1.029021,"high":-0.443678,"avg":-3.536895,"sd":3.816542,"marketCap":3155815451},"quantilePoints":[{"date":"2024-06-28","current":-4.084559,"twenty":-4.913756,"median":-4.913756,"eighty":-4.416238,"marketCap":689534895},{"date":"2024-07-05","current":-3.516406,"twenty":-4.747917,"median":-3.851156,"eighty":-3.59564,"marketCap":593622147},{"date":"2024-07-12","current":-3.405847,"twenty":-4.063676,"median":-3.825051,"eighty":-3.58397,"marketCap":574958044},{"date":"2024-07-19","current":-4.023985,"twenty":-4.026561,"median":-3.851156,"eighty":-3.52869,"marketCap":679309112},{"date":"2024-07-26","current":-4.023985,"twenty":-4.117224,"median":-3.947896,"eighty":-3.58397,"marketCap":679309112},{"date":"2024-08-02","current":-4.178507,"twenty":-4.123137,"median":-3.980142,"eighty":-3.620209,"marketCap":705394582},{"date":"2024-08-09","current":-3.850149,"twenty":-4.108328,"median":-3.938677,"eighty":-3.693301,"marketCap":649962958},{"date":"2024-08-16","current":-3.683794,"twenty":-4.085032,"median":-3.914533,"eighty":-3.659692,"marketCap":696362265},{"date":"2024-08-23","current":-3.672282,"twenty":-4.078883,"median":-3.855481,"eighty":-3.667968,"marketCap":694186133},{"date":"2024-08-30","current":-3.655014,"twenty":-4.050383,"median":-3.84693,"eighty":-3.659692,"marketCap":690921935},{"date":"2024-09-06","current":-3.442045,"twenty":-4.027205,"median":-3.798947,"eighty":-3.608967,"marketCap":650663491},{"date":"2024-09-13","current":-3.33556,"twenty":-4.023985,"median":-3.741353,"eighty":-3.511116,"marketCap":630534270},{"date":"2024-09-20","current":-3.301025,"twenty":-4.023985,"median":-3.709695,"eighty":-3.405847,"marketCap":624005873},{"date":"2024-09-27","current":-3.211808,"twenty":-3.980142,"median":-3.685233,"eighty":-3.395997,"marketCap":607140850},{"date":"2024-10-04","current":-2.803137,"twenty":-3.959602,"median":-3.672282,"eighty":-3.303903,"marketCap":529888161},{"date":"2024-10-11","current":-2.978693,"twenty":-3.946725,"median":-3.656453,"eighty":-3.263611,"marketCap":563074175},{"date":"2024-10-18","current":-3.462191,"twenty":-3.930629,"median":-3.608967,"eighty":-3.220442,"marketCap":654471723},{"date":"2024-10-25","current":-3.424777,"twenty":-3.915649,"median":-3.608753,"eighty":-3.22332,"marketCap":647399293},{"date":"2024-11-01","current":-3.254977,"twenty":-3.914533,"median":-3.516406,"eighty":-3.231953,"marketCap":615301345},{"date":"2024-11-08","current":-3.459313,"twenty":-3.86344,"median":-3.50536,"eighty":-3.240587,"marketCap":653927690},{"date":"2024-11-15","current":-2.016571,"twenty":-3.859807,"median":-3.465068,"eighty":-3.22332,"marketCap":481504843},{"date":"2024-11-22","current":-2.155567,"twenty":-3.851156,"median":-3.454996,"eighty":-3.18015,"marketCap":514693313},{"date":"2024-11-29","current":-2.109995,"twenty":-3.85035,"median":-3.444923,"eighty":-3.067334,"marketCap":503811848},{"date":"2024-12-06","current":-2.050751,"twenty":-3.847574,"median":-3.439167,"eighty":-2.978693,"marketCap":489665943},{"date":"2024-12-13","current":-1.911755,"twenty":-3.823752,"median":-3.419021,"eighty":-2.94646,"marketCap":456477473},{"date":"2024-12-20","current":-2.009736,"twenty":-3.802749,"median":-3.405847,"eighty":-2.329653,"marketCap":479872624},{"date":"2024-12-27","current":-1.836561,"twenty":-3.764391,"median":-3.395997,"eighty":-2.153744,"marketCap":438523055},{"date":"2025-01-03","current":-1.925427,"twenty":-3.741353,"median":-3.367218,"eighty":-2.142807,"marketCap":459741913},{"date":"2025-01-10","current":-1.595028,"twenty":-3.741353,"median":-3.312536,"eighty":-2.023407,"marketCap":380851289},{"date":"2025-01-17","current":-1.745417,"twenty":-3.740777,"median":-3.298147,"eighty":-1.989684,"marketCap":416760124},{"date":"2025-01-24","current":-1.522113,"twenty":-3.738475,"median":-3.27944,"eighty":-1.964163,"marketCap":363440944},{"date":"2025-01-31","current":-1.704402,"twenty":-3.735597,"median":-3.263611,"eighty":-1.93682,"marketCap":406966805},{"date":"2025-02-07","current":-1.291973,"twenty":-3.709695,"median":-3.247782,"eighty":-1.911755,"marketCap":308489544},{"date":"2025-02-14","current":-1.187157,"twenty":-3.703939,"median":-3.22332,"eighty":-1.873019,"marketCap":283462173},{"date":"2025-02-21","current":-1.178042,"twenty":-3.690125,"median":-3.211808,"eighty":-1.829725,"marketCap":281285880},{"date":"2025-02-28","current":-1.059555,"twenty":-3.68437,"median":-3.162882,"eighty":-1.759544,"marketCap":252994070},{"date":"2025-03-07","current":-1.111963,"twenty":-3.676887,"median":-3.070787,"eighty":-1.711693,"marketCap":265507755},{"date":"2025-03-14","current":-1.041326,"twenty":-3.672858,"median":-3.006033,"eighty":-1.678881,"marketCap":248641484},{"date":"2025-03-21","current":-0.693421,"twenty":-3.667968,"median":-2.978693,"eighty":-1.565406,"marketCap":204027476},{"date":"2025-03-28","current":-1.042906,"twenty":-3.659692,"median":-2.965742,"eighty":-1.505251,"marketCap":306857324},{"date":"2025-04-04","current":-1.85837,"twenty":-3.65559,"median":-2.803137,"eighty":-1.500694,"marketCap":546793636},{"date":"2025-04-11","current":-1.198232,"twenty":-3.63199,"median":-2.286587,"eighty":-1.463027,"marketCap":352559478},{"date":"2025-04-17","current":-0.924562,"twenty":-3.622781,"median":-2.176074,"eighty":-1.280365,"marketCap":272036635},{"date":"2025-04-25","current":-0.791425,"twenty":-3.613572,"median":-2.146452,"eighty":-1.183511,"marketCap":232863359},{"date":"2025-05-02","current":-0.848748,"twenty":-3.60871,"median":-2.125945,"eighty":-1.162092,"marketCap":249729630},{"date":"2025-05-09","current":-0.930109,"twenty":-3.590112,"median":-2.016571,"eighty":-1.140673,"marketCap":273668854},{"date":"2025-05-16","current":-0.890525,"twenty":-3.561975,"median":-1.997203,"eighty":-1.105127,"marketCap":305759157},{"date":"2025-05-23","current":-0.766929,"twenty":-3.530406,"median":-1.968721,"eighty":-1.070948,"marketCap":263322832},{"date":"2025-05-30","current":-0.619565,"twenty":-3.51429,"median":-1.964163,"eighty":-1.045883,"marketCap":212725677},{"date":"2025-06-06","current":-0.530829,"twenty":-3.506511,"median":-1.95277,"eighty":-1.037224,"marketCap":182258572},{"date":"2025-06-13","current":-0.503891,"twenty":-3.48667,"median":-1.925427,"eighty":-0.984896,"marketCap":173009629},{"date":"2025-06-20","current":-0.476954,"twenty":-3.466829,"median":-1.916313,"eighty":-0.943233,"marketCap":163760687},{"date":"2025-06-27","current":-0.522906,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"marketCap":179538295},{"date":"2025-07-03","current":-0.538752,"twenty":-3.462191,"median":-1.878715,"eighty":-0.88573,"marketCap":184978849},{"date":"2025-07-11","current":-0.564105,"twenty":-3.459313,"median":-1.85837,"eighty":-0.848748,"marketCap":193683736},{"date":"2025-07-18","current":-0.556182,"twenty":-3.450679,"median":-1.833144,"eighty":-0.808067,"marketCap":190963459},{"date":"2025-07-25","current":-0.611642,"twenty":-3.444923,"median":-1.819538,"eighty":-0.791425,"marketCap":210005399},{"date":"2025-08-01","current":-0.65601,"twenty":-3.444923,"median":-1.768203,"eighty":-0.766929,"marketCap":225238952},{"date":"2025-08-08","current":-1.301335,"twenty":-3.442045,"median":-1.745417,"eighty":-0.761839,"marketCap":446809517},{"date":"2025-08-15","current":-2.007939,"twenty":-3.439167,"median":-1.743138,"eighty":-0.765537,"marketCap":456842285},{"date":"2025-08-22","current":-2.103991,"twenty":-3.427655,"median":-1.761367,"eighty":-0.766929,"marketCap":478695789},{"date":"2025-08-29","current":-2.14973,"twenty":-3.424777,"median":-1.805264,"eighty":-0.766929,"marketCap":489102219},{"date":"2025-09-05","current":-2.103991,"twenty":-3.415567,"median":-1.826307,"eighty":-0.771366,"marketCap":478695789},{"date":"2025-09-12","current":-1.994217,"twenty":-3.40866,"median":-1.836561,"eighty":-0.773109,"marketCap":453720356},{"date":"2025-09-19","current":-1.9622,"twenty":-3.406179,"median":-1.867544,"eighty":-0.787793,"marketCap":446435855},{"date":"2025-09-26","current":-1.824983,"twenty":-3.405847,"median":-1.875296,"eighty":-0.795863,"marketCap":415216564},{"date":"2025-10-03","current":-1.811262,"twenty":-3.397967,"median":-1.860219,"eighty":-0.799931,"marketCap":412094635},{"date":"2025-10-10","current":-2.071974,"twenty":-3.391392,"median":-1.873019,"eighty":-0.803629,"marketCap":471411288},{"date":"2025-10-17","current":-2.108565,"twenty":-3.371823,"median":-1.884428,"eighty":-0.807327,"marketCap":479736432},{"date":"2025-10-24","current":-2.108565,"twenty":-3.341892,"median":-1.893592,"eighty":-0.812505,"marketCap":479736432},{"date":"2025-10-31","current":-2.131434,"twenty":-3.317141,"median":-1.904969,"eighty":-0.82249,"marketCap":484939647},{"date":"2025-11-07","current":-2.158878,"twenty":-3.30563,"median":-1.911755,"eighty":-0.843135,"marketCap":491183505},{"date":"2025-11-14","current":-2.422653,"twenty":-3.301601,"median":-1.918592,"eighty":-0.848547,"marketCap":551197167},{"date":"2025-11-21","current":-2.946741,"twenty":-3.29642,"median":-1.93682,"eighty":-0.86502,"marketCap":722402348},{"date":"2025-11-28","current":-3.266113,"twenty":-3.290089,"median":-1.953052,"eighty":-0.869088,"marketCap":800697401},{"date":"2025-12-05","current":-3.534386,"twenty":-3.297571,"median":-1.962042,"eighty":-0.870197,"marketCap":866465244},{"date":"2025-12-12","current":-4.943882,"twenty":-3.336738,"median":-1.966442,"eighty":-0.879813,"marketCap":1212007408},{"date":"2025-12-19","current":-4.709675,"twenty":-3.399937,"median":-1.972322,"eighty":-0.888607,"marketCap":1154591037},{"date":"2025-12-26","current":-4.854457,"twenty":-3.410963,"median":-1.990368,"eighty":-0.898223,"marketCap":1190084794},{"date":"2026-01-02","current":-4.156097,"twenty":-3.436865,"median":-1.996504,"eighty":-0.911618,"marketCap":1018879613},{"date":"2026-01-09","current":-7.741582,"twenty":-3.449528,"median":-2.003365,"eighty":-0.920124,"marketCap":1897872066},{"date":"2026-01-16","current":-12.290084,"twenty":-3.466829,"median":-2.013154,"eighty":-0.925671,"marketCap":3012950964},{"date":"2026-01-23","current":-13.362987,"twenty":-3.516406,"median":-2.019374,"eighty":-0.930109,"marketCap":3275976472},{"date":"2026-01-30","current":-13.647739,"twenty":-3.577828,"median":-2.030809,"eighty":-0.937506,"marketCap":3345784190},{"date":"2026-02-06","current":-13.393497,"twenty":-3.626234,"median":-2.053678,"eighty":-0.942816,"marketCap":3283455871},{"date":"2026-02-13","current":-13.6274,"twenty":-3.672282,"median":-2.062826,"eighty":-0.944902,"marketCap":3340797925},{"date":"2026-02-20","current":-14.850306,"twenty":-3.690125,"median":-2.071974,"eighty":-0.965612,"marketCap":3640597141},{"date":"2026-02-27","current":-15.244382,"twenty":-3.739051,"median":-2.087982,"eighty":-0.981145,"marketCap":3737206037},{"date":"2026-03-06","current":-14.054527,"twenty":-3.801818,"median":-2.103991,"eighty":-0.986058,"marketCap":3445509501},{"date":"2026-03-13","current":-12.727381,"twenty":-3.85035,"median":-2.108565,"eighty":-0.99467,"marketCap":3120155674},{"date":"2026-03-20","current":-13.002303,"twenty":-3.914756,"median":-2.117713,"eighty":-1.01599,"marketCap":3163785497},{"date":"2026-03-26","current":-12.969549,"twenty":-3.951876,"median":-2.122286,"eighty":-1.029021,"marketCap":3155815451}],"updateTime":1774650175061},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618916466","title":"U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2618916466","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618916466?lang=en_us&edition=fundamental","pubTime":"2026-03-11 15:10","pubTimestamp":1773213002,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, OracleMarch 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Wednesday, includin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ0GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HWM","ORCS","AVR","BSX","ALMS","APYX","ORCU","RNA","HIMY","HIMZ","HAS","BMRN","CDW","GEHC","T","HAE","REGN","DXCM","CNCG","NKE","UEC","ELV","HMYY","BLND","CHH","ORCL","DBI","AVAV","CASY","ABT","CRBG","FICO","EXPE","PGNY","SJM","HIMS","BKNG","HLT","AVXX","H","ADC","EPRT","BKNU","ABM","MET","ORCX","CNC","CLYM","HOG","HIYY"],"gpt_icon":1},{"id":"2618696469","title":"Alumis initiated with a Strong Buy at Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2618696469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618696469?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:10","pubTimestamp":1773173432,"startTime":"0","endTime":"0","summary":"Raymond James initiated coverage of Alumis (ALMS) with a Strong Buy rating and $46 price target The company’s lead asset envudeucitinib is well pos...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-initiated-with-a-strong-buy-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-initiated-with-a-strong-buy-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RJF","LU0971096721.USD","LU1363072403.SGD","IE00B3QW5Z07.USD","LU2265009873.SGD","LU1804176565.USD","ALMS","BK4585","IE00B64PRP62.GBP","BK4127","BK4007","IE00BGHQF748.EUR","BK4588"],"gpt_icon":0},{"id":"2616332021","title":"Alumis CEO Martin Babler to Join Fireside Chat at Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332021","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616332021?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:06","pubTimestamp":1772456771,"startTime":"0","endTime":"0","summary":"Alumis CEO Martin Babler to Join Fireside Chat at Leerink Partners Global Healthcare Conference               Alumis Inc. said its President and CEO Martin Babler will participate in a fireside chat a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL4VRhCt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4585","SG9999014021.USD","IE00BGHQF748.EUR","BK4007","LU0314104364.USD","IE00B3QW5Z07.USD","BK4207","LU2210149790.SGD","SG9999014039.USD","BK4588","LU2095319765.USD","BK4112","MNSH","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014005.SGD","NDAQ","SG9999014013.SGD","ALMS"],"gpt_icon":0},{"id":"2614082899","title":"Alumis Inc : Stifel Initiates Coverage With Buy Rating; Price Target $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2614082899","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614082899?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:53","pubTimestamp":1772024016,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL1AV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2614817150","title":"Stifel Initiates Alumis at Buy With $44 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2614817150","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614817150?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:20","pubTimestamp":1772022058,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has an average rating of buy and mean price target of $38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and resea","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","ALMS"],"gpt_icon":0},{"id":"2614213703","title":"U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP","url":"https://stock-news.laohu8.com/highlight/detail?id=2614213703","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614213703?lang=en_us&edition=fundamental","pubTime":"2026-02-25 15:20","pubTimestamp":1772004027,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HPFeb 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Chevron, GoDaddy and HP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL4N3ZL0IC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSGP","CVX","AMT","CAT","BEAM","CEG","IPSC","AMDL","CCUP","CEGX","BMY","AUGO","AMYY","ICRC","CYTK","AFL","AMDG","SAM","ATRO","AMDU","AMDY","AXON","ABBV","ALMS","CAVA","CDNA","CRBG","BBIO","BIOA","BWIN","ADUS","AMDD","CZR","ANGX","AMUU","BMRN","BOW","BAM","AMD","AU","CECO","GLW","CORT","CRCG","CRCL","CRL","BCC","BURL","CRCD","AVB"],"gpt_icon":0},{"id":"2609082593","title":"Alumis to Participate in Upcoming February Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2609082593","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609082593?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:05","pubTimestamp":1770296700,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Feb.  05, 2026  (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-media","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/05/3232969/0/en/Alumis-to-Participate-in-Upcoming-February-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2605104192","title":"Alumis Initiated at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605104192","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605104192?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:35","pubTimestamp":1768998900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 21, 2026 07:35 ET (12:35 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2605104383","title":"Chardan Initiates Alumis at Buy With $37 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2605104383","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605104383?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:20","pubTimestamp":1768998055,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has an average rating of buy and mean price target of $37.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS"],"gpt_icon":0},{"id":"2605174452","title":"Alumis Inc. (ALMS) Receives a Buy from Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605174452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605174452?lang=en_us&edition=fundamental","pubTime":"2026-01-21 16:35","pubTimestamp":1768984558,"startTime":"0","endTime":"0","summary":"Chardan Capital analyst initiated coverage with a Buy rating on Alumis Inc. today and set a price target of $37.00. In addition to Chardan Capital,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alumis-inc-alms-receives-a-buy-from-chardan-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alumis-inc-alms-receives-a-buy-from-chardan-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2604104679","title":"13D Filings -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2604104679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604104679?lang=en_us&edition=fundamental","pubTime":"2026-01-17 09:39","pubTimestamp":1768613940,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Jan. 8 through Jan. 14, 2026. Source: VerityData. Monte Rosa Therapeutics Versant Venture Capital VI reduced its stake in the biotechnology company to 3,250,069 shares. Versant Venture Capital did so through the sale of 597,931 Monte Rosa Therapeutics shares from Nov. 19, 2025, through Jan. 7, 2026, at per share prices ranging from $14.25 to $23.33, and also completed pro rata distributions of 500,030 shares on Dec. 4 and 560,092 shares on Jan. 8. Following the latest activity, Versant Venture Capital continues to own a 4.99% stake in Monte Rosa Therapeutics' outstanding stock, placing Ve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4007","VTOL","ASTE","GLUE","BK4149","BK4179","ALMS","BK4539","BK4139","BK4198","BK4585","STAA","BK4588"],"gpt_icon":0},{"id":"2603043116","title":"Alumis (ALMS) Is Up 35.8% After Psoriasis Data And $300M Raise Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603043116","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603043116?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:32","pubTimestamp":1768465924,"startTime":"0","endTime":"0","summary":"Earlier in January 2026, Alumis Inc. reported positive topline Phase 3 ONWARD1 and ONWARD2 results for its oral TYK2 inhibitor envudeucitinib in moderate-to-severe plaque psoriasis and subsequently completed a US$300.05 million follow-on common stock offering at US$17.00 per share.\nA key angle for investors is how envudeucitinib’s differentiated clinical profile and “pipeline-in-a-pill” potential, including possible applications in systemic lupus erythematosus, could influence Alumis’s...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/alumis-alms-is-up-358-after-psoriasis-data-and-300m-raise-ha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/alumis-alms-is-up-358-after-psoriasis-data-and-300m-raise-ha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2603645362","title":"Alumis rises 10.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603645362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603645362?lang=en_us&edition=fundamental","pubTime":"2026-01-15 01:07","pubTimestamp":1768410456,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) is up 10.2%, or $2.26 to $24.37. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-rises-10-2-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-rises-10-2-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2603650863","title":"Insider Makes Bold Multimillion-Dollar Bet on Alumis Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2603650863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603650863?lang=en_us&edition=fundamental","pubTime":"2026-01-14 10:01","pubTimestamp":1768356112,"startTime":"0","endTime":"0","summary":"New insider activity at Alumis Inc. ( ($ALMS) ) has taken place on January 13, 2026. Director Srinivas Akkaraju has made a significant insider purc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-makes-bold-multimillion-dollar-bet-on-alumis-inc-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-makes-bold-multimillion-dollar-bet-on-alumis-inc-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"1139751814","title":"Form 4 | Alumis Inc. Director Akkaraju Srinivas acquired 588,235 shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1139751814","media":"Filings Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139751814?lang=en_us&edition=fundamental","pubTime":"2026-01-14 07:25","pubTimestamp":1768346733,"startTime":"0","endTime":"0","summary":"Akkaraju Srinivas, Director of Alumis Inc., acquired 588,235 shares of common stock on January 9, 2026, at a price of $17 per share via Samsara Opportunity Fund, L.P. This transaction indicates...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Form 4 | Alumis Inc. Director Akkaraju Srinivas acquired 588,235 shares.","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":1},{"id":"1105451311","title":"ALUMIS INC. Director Foresite Capital Management VI LLC purchased 411,764 Shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1105451311","media":"Filings Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105451311?lang=en_us&edition=fundamental","pubTime":"2026-01-13 11:20","pubTimestamp":1768274427,"startTime":"0","endTime":"0","summary":"ALUMIS INC. Director Foresite Capital Management VI LLC conducted 2 purchases on January 8, 2026, totaling 411,764 shares at a price of $17 per share. The increase in holdings is usually seen as a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"1100853925","title":"ALUMIS Inc. Director James B. Tananbaum purchased 411,764 Shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1100853925","media":"Filings Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100853925?lang=en_us&edition=fundamental","pubTime":"2026-01-13 11:12","pubTimestamp":1768273933,"startTime":"0","endTime":"0","summary":"ALUMIS Inc. (ALMS) Director James B. Tananbaum purchased 411,764 shares of common stock on January 8, 2026, at a price of $17 per share. After the purchase, James B. Tananbaum indirectly holds...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":1},{"id":"2603576414","title":"Foresite Labs Reports Acquisition of Alumis Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603576414","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603576414?lang=en_us&edition=fundamental","pubTime":"2026-01-13 10:59","pubTimestamp":1768273181,"startTime":"0","endTime":"0","summary":"Foresite Labs, LLC and Foresite Labs Affiliates 2021, LLC reported the acquisition of common shares of Alumis Inc. , according to a recent SEC filing. Other reporting beneficial owners were also listed in the filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL6Kbzw0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":1},{"id":"2603576172","title":"Director and 10% Owner James B. Tananbaum Acquires Common Shares of Alumis Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2603576172","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603576172?lang=en_us&edition=fundamental","pubTime":"2026-01-13 10:58","pubTimestamp":1768273138,"startTime":"0","endTime":"0","summary":"James B. Tananbaum, a Director and 10% Owner, reported the acquisition of common shares of Alumis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL3d9MB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner James B. Tananbaum Acquires Common Shares of Alumis Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":1},{"id":"2602510564","title":"Alumis Inc. Showcases Breakthrough TYK2 Inhibitor Results for Psoriasis and Lupus","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510564","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510564?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:01","pubTimestamp":1768222884,"startTime":"0","endTime":"0","summary":"Alumis Inc. has released a corporate presentation detailing recent advancements in its pipeline of precision-engineered TYK2 inhibitors for immune-mediated diseases. The company highlighted positive topline data from its Phase 3 ONWARD1 and ONWARD2 clinical trials, demonstrating that its lead candidate, envudeucitinib, achieved highly statistically significant efficacy in moderate-to-severe plaque psoriasis. The therapy showed rapid onset of action, deep skin clearance at 24 weeks, and improvements in quality of life and itch, with a safety profile consistent with prior studies. The presentation also outlined ongoing development of envudeucitinib for systemic lupus erythematosus and next-generation TYK2 inhibitor programs targeting neuroinflammation and other indications. Additional long-term psoriasis data and lupus trial results are expected in the second half of 2026. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Techno","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDLbMMvz0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":1}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":116,"code":"91000000","status":"200"}]}}